Page last updated: 2024-11-02

oxophenylarsine and Hepatocellular Carcinoma

oxophenylarsine has been researched along with Hepatocellular Carcinoma in 2 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with diamide and PAO rapidly prevented the inducer-dependent formation of the Ah receptor/xenobiotic response element complex detected by electrophoretic mobility shift assays and suppressed Ah receptor-mediated transcription."1.30DNA binding activity of the aryl hydrocarbon receptor is sensitive to redox changes in intact cells. ( Pasco, DS; Siu, CS; Xu, C, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, P1
Zhang, YH1
Zheng, XW1
Liu, YJ1
Zhang, H1
Fang, L1
Zhang, YW1
Yang, C1
Islam, K1
Wang, C1
Naranmandura, H1
Xu, C1
Siu, CS1
Pasco, DS1

Other Studies

2 other studies available for oxophenylarsine and Hepatocellular Carcinoma

ArticleYear
Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
    Metallomics : integrated biometal science, 2017, 12-01, Volume: 9, Issue:12

    Topics: Apoptosis; Arsenicals; Carcinoma, Hepatocellular; Endoplasmic Reticulum Stress; Humans; Liver Neopla

2017
DNA binding activity of the aryl hydrocarbon receptor is sensitive to redox changes in intact cells.
    Archives of biochemistry and biophysics, 1998, Oct-01, Volume: 358, Issue:1

    Topics: Animals; Arsenicals; Biological Transport; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Diami

1998